We’re proud to share our latest research, conducted in collaboration with the Etablissement Français du Sang (EFS), now published in Hepatology Communications! This study showcases the potential of PD...

We are thrilled to announce that BioProcess International, a leading global platform for the bioprocessing industry, has published a new article featuring an interview with our CEO, Eric Halioua. In...

We are very pleased to announce the publication of a new scientific paper in the peer-reviewed journal "The Journal of Immunology". Title of the article is: "Development of a New Off-the-Shelf...

We are very pleased to announce the publication of a new article with an interview of our CEO Eric Halioua published this week in the magazine PharmaBoardroom, the global platform for healthcare &...

Eric Halioua, President & CEO at PDC*line Pharma Shares Insights on the Results from ongoing PDC-LUNG-101 clinical trial

We are very pleased to announce that a new article, following an interview of...

We are very pleased to inform you about the publication of a new scientific paper in the peer-reviewed journal "Genes and Cancer" as a "Research Perspective". Article is entitled: Leveraging a...

We are very pleased to inform you about the publication of a new scientific article in the "International Journal of Molecular Sciences" in a special issue entitled "Dendritic Cell and Cancer Therapy...

We are delighted to announce of the publication by our CSO Joël Plumas of a new review article in scientific journal Current Opinion in Oncology and intitled "Harnessing dendritic cells for innovative...

Available now for replay, the interview of PDC*line Pharma 's President & CEO Eric Halioua by journalist of the program « Itinéraires santé » in the TV studio of the French Media group Le Figaro. 

In...

In replay, the intervention of our CEO Eric Halioua and one of our investors Marc Foidart of the Noshaq fund on Monday May 17th at the "Success stories" program dedicated to the Biotechnology on the...